Michael Barbella08.09.23
Sleep technology company REMware has signed an agreement with Side Health to provide sleep apnea testing services for detecting and treating undiagnosed sleep apnea among the latter's patients.
REMware’s home sleep testing patented process—DreamClear—simplifies and accelerates the diagnostic process for Side Health’s patients and providers, according to REMware CEO Arun Ramabadran. Side Health specializes in fully-integrated care, including comprehensive remote patient monitoring, to help patients with multiple medical conditions better manage their care.
“The 2023 data shows 26z of the U.S. adult population, ages 30 to 70, have sleep apnea, which is a serious condition linked to a wide array of health issues, including cardiovascular disease, hypertension and diabetes. In fact, studies show half of all hospital patients with hypertension have sleep apnea, and untreated sleep apnea sufferers are three times as likely to have heart disease and have a four times greater risk of suffering a stroke,” Side Health Co-Founder/CEO Dr. Kanwar Kelley said.
REMware maintains a 99% success rate in working with providers to complete the DreamClear home sleep test, due primarily to its technology platform with automated texts, email, app notifications, and in-house personal support services.
The proprietary technology and process yields the same assessment of obstructive sleep apnea and central sleep apnea when compared to in-lab polysomnography tests, giving providers the opportunity to treat, educate and provide follow-up care virtually and in the comfort of their home, said Ramabadran.
“REMware’s approach to business is identical to ours: provide the highest quality of care, technology and education so the patient has improved health outcomes and groups have a lower total cost of care,” Kelley said.
REMware designs and improves sleep medicine technologies to help diagnose the approximately 1 billion people worldwide with sleep apnea. In addition to its advanced home sleep testing (HST) program, REMware also delivers software that automates the back-office operations for HST and in-lab operations. REMware is based in Tampa, Fla., and serves clients nationwide.
Side Health is a virtual first medical practice focused on delivering specialty care for patients with chronic medical conditions like hypertension, diabetes, heart disease, COPD, allergies, sleep apnea, and more. Side Health partners with health plans and providers to provide care of their sickest patients while reducing their total cost of care.
REMware’s home sleep testing patented process—DreamClear—simplifies and accelerates the diagnostic process for Side Health’s patients and providers, according to REMware CEO Arun Ramabadran. Side Health specializes in fully-integrated care, including comprehensive remote patient monitoring, to help patients with multiple medical conditions better manage their care.
“The 2023 data shows 26z of the U.S. adult population, ages 30 to 70, have sleep apnea, which is a serious condition linked to a wide array of health issues, including cardiovascular disease, hypertension and diabetes. In fact, studies show half of all hospital patients with hypertension have sleep apnea, and untreated sleep apnea sufferers are three times as likely to have heart disease and have a four times greater risk of suffering a stroke,” Side Health Co-Founder/CEO Dr. Kanwar Kelley said.
REMware maintains a 99% success rate in working with providers to complete the DreamClear home sleep test, due primarily to its technology platform with automated texts, email, app notifications, and in-house personal support services.
The proprietary technology and process yields the same assessment of obstructive sleep apnea and central sleep apnea when compared to in-lab polysomnography tests, giving providers the opportunity to treat, educate and provide follow-up care virtually and in the comfort of their home, said Ramabadran.
“REMware’s approach to business is identical to ours: provide the highest quality of care, technology and education so the patient has improved health outcomes and groups have a lower total cost of care,” Kelley said.
REMware designs and improves sleep medicine technologies to help diagnose the approximately 1 billion people worldwide with sleep apnea. In addition to its advanced home sleep testing (HST) program, REMware also delivers software that automates the back-office operations for HST and in-lab operations. REMware is based in Tampa, Fla., and serves clients nationwide.
Side Health is a virtual first medical practice focused on delivering specialty care for patients with chronic medical conditions like hypertension, diabetes, heart disease, COPD, allergies, sleep apnea, and more. Side Health partners with health plans and providers to provide care of their sickest patients while reducing their total cost of care.